Jun 25, 2024 · About 296 million people aged 15-64 had used psychoactive drugs in 2021 and about 39.5 million people are estimated to be affected by drug use disorders (harmful pattern …

WHO Drug Information provides an overview of topics relating to drug development and regulation that are of current relevance and importance, and includes the lists of proposed and …

The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce …

The first is regulatory issues, which can affect how medicines are bought to market, create lag times and cause the supply of medicines in some areas of the globe to be delayed long after …

Mar 13, 2025 · The recommendations were developed by WHO Expert Committee on Drug Dependence--ECDD, which consists of global experts analyzing health risks and benefits of …

The use of psychoactive drugs and psychotropic substances without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. …

Out of 600,000 deaths attributed to drug use, about 450 000 are due to use of opioids according to the latest WHO estimates. It is crucial that people with opioid dependence and those at risk …

WHO promotes global drug safety through its Programme for International Drug Monitoring (PIDM), which began in the 1960s. Through the cooperative effort, Member States and WHO …

May 17, 2024 · “By mapping the global burden of drug-resistant bacteria and assessing their impact on public health, this list is key to guiding investment and grappling with the antibiotics …

236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products.